Rehmann Capital Advisory Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-361
| Closed | -$622K | – | 572 |
|
|
2021
Q3 | $622K | Sell |
361
-7,301
| -95% | -$12.6M | 0.06% | 277 |
|
|
2021
Q2 | $1.32M | Buy |
+7,662
| New | +$1.32M | 0.13% | 135 |
|
|
2020
Q2 | – | Sell |
-12,336
| Closed | -$523K | – | 421 |
|
|
2020
Q1 | $523K | Buy |
+12,336
| New | +$523K | 0.09% | 195 |
|
|
2019
Q3 | $1.27K | Hold |
31
| – | – | ﹤0.01% | 1513 |
|
|
2019
Q2 | $1.46K | Hold |
31
| – | – | ﹤0.01% | 1849 |
|
|
2019
Q1 | $1.11K | Hold |
31
| – | – | ﹤0.01% | 1911 |
|
|
2018
Q4 | $885 | Hold |
31
| – | – | ﹤0.01% | 1680 |
|
|
2018
Q3 | $1.37K | Hold |
31
| – | – | ﹤0.01% | 1907 |
|
|
2018
Q2 | $1.82K | Buy |
+31
| New | +$1.82K | ﹤0.01% | 1830 |
|